Why Join the Annual TCR-Based Therapies Summit?
TCR-based therapies have reached a defining moment: clinical success in oncology has validated the modality, while emerging programs beyond cancer are opening entirely new therapeutic frontiers. Despite this progress, high cost of goods, narrow patient populations, and variable durability continue to limit scalability, investment, and long-term commercial success.
The next wave of TCR innovation must move beyond proof-of-concept to deliver new platforms, optimized formats, and smarter development strategies that redefine potency, persistence, and commercial viability.
The 7th TCR-Based Therapies Summit returned at this pivotal inflection point, remaining the definitive forum dedicated to advancing the future of TCR-based cell and biologic therapies. Uniting the close-knit TCR community, this meeting responded to the most urgent scientific, translational, and commercial challenges shaping the field today.
Across three focused days, attendees learnt directly from industry pioneers at Immatics, Immunocore, Regeneron, BioNTech, Enara Bio, Zelluna Immunotherapy and more, as they shared real-world lessons in advancing TCR therapies from discovery through to clinical development, manufacturing, and commercialization. Delegates left equipped with the insights needed to develop the scalable, durable, and commercially viable TCR platforms of tomorrow.
2026 Event Highlights
Collaborate Closely with Experts in Interactive Workshops
Dive into our pre-conference workshops, where experts from Enara Bio, MD Anderson, and T-knife Therapeutics will explore next-generation target discovery and advanced engineering strategies. Learn how novel antigens, non-canonical targets, and multi-target approaches are expanding patient reach and improving treatment durability.
Accelerate Development Without Sacrificing Safety or Efficacy
Discover how AI, machine learning, and advanced screening technologies are accelerating affinity maturation, enhancing specificity, and enabling safer, more efficient engineering decisions, to shorten development timelines without compromising efficacy.
Convert Scientific Innovation into Commercial Value
Understand how developers at Anocca, Zelluna Immunotherapy, and 3T Biosciences are addressing challenges in manufacturing, cost of goods, and commercialization with novel platform-level strategies that transition TCR therapies from bespoke innovation to commercially viable solutions.
Build the Partnerships That Advance Your Pipeline
Connect with the global TCR community through a dedicated poster session, speed networking sessions, interactive discussions, and curated networking opportunities, designed to foster meaningful collaborations and accelerate progress across TCR-based cell and biologic therapies.
Delve into the Complete 2026 Event Program
Find Inside...
- Interactive Workshops on Next-Generation TCR Targets & Novel Engineering Strategies
- Unrivalled Networking Opportunities with Industry-Leading TCR Developers
- Brand-New Data Presentations Led by Top Biopharma Professionals
- Insight into the Only Meeting Dedicated to TCR-Based Therapy Advancement
Attending Companies Included
Discover the 2026 Agenda
See the agenda delivering the latest breakthroughs and real-world insights on TCR-T, TCR mimetics, TCR-TCEs, and TCR bispecifics.
Partner With the Future
Position your brand at the center of the TCR ecosystem by partnering with leading developers shaping the future of TCR-based therapies.
Collaborate With TCR Experts
Connect with senior leaders across biopharma and academia during high-value networking sessions and the scientific poster session.